SEQUENT Share Price Discussion

Sequent Scientific Ltd.
Sector: Pharmaceuticals and health care

SEQUENT Share Price *

87.25 +3.5 (4.18%)

* (quote may be delayed)

SEQUENT Discussion Forum

HALAL INVESTMENT @ShoyabHafeji

SEQUENT

•

Aug 29 8:11 PM

HALAL INVESTMENT in SEQUENT
SEQUENT ACHV 2ND TARGET..HOLD 4 NEXT...❣

SEQUENT ❣
2DAY AGAIN GV MY VIEW 4 🆚️ 82+ AT 77 LVL IN WHATSAPP GROUP...❣

HALAL INVESTMENT @ShoyabHafeji

SEQUENT

•

Aug 27 8:27 PM

HALAL INVESTMENT in SEQUENT
SEQUENT...71.45 BUY RANGE 70 TO 68 PUT 66 AS CB...

SEQUENT ACHV 2ND TARGET..HOLD 4 NEXT...❣

HALAL INVESTMENT @ShoyabHafeji

SEQUENT

•

Aug 27 6:10 PM

HALAL INVESTMENT
SEQUENT...71.45 BUY RANGE 70 TO 68 PUT 66 AS CB...

SEQUENT ACHV 1ST TARGET...❣ HOLD ON

NewsBot @newsbot

SEQUENT

•

Aug 21 3:28 PM

Sequent Scientific climbs 4% on EIR from USFDA for Bengaluru laboratory
The Bengaluru laboratory was set up in 2017 to cater to the growing analytical requirements of large pharmaceutical and FMCG majors in the region.

Moneycontrol

https://www.moneycontrol.com/news/business/markets/sequen...

HALAL INVESTMENT @ShoyabHafeji

SEQUENT

•

Aug 21 1:54 PM

SEQUENT...71.45
BUY RANGE 70 TO 68
PUT 66 AS CBSL
EXPECT TARGET 75/78/80+

NewsBot @newsbot

SEQUENT

•

Apr 16 10:18 PM

Buy Sequent Scientific; target of Rs 116: Joindre Capital Services
https://www.moneycontrol.com/news/business/stocks/buy-sequent-scientific-target-of-rs-116-joindre-capital-services-3834031.html

NewsBot @newsbot

SEQUENT

•

Dec 19 7:57 PM

Ten BSE 500 stocks rise 45-100% since October. Do you own any?
https://www.moneycontrol.com/news/business/markets/ten-bse-500-stocks-rise-45-100-since-october-do-you-own-any-3305601.html

NewsBot @newsbot

SEQUENT

•

Dec 19 7:37 PM

Ten BSE 500 stocks rose 45-100% in 2018. Do you own any?
https://www.moneycontrol.com/news/business/markets/ten-bse-500-stocks-rose-45-100-in-2018-do-you-own-any-3305601.html

NewsBot @newsbot

SEQUENT

•

Dec 13 7:02 PM

Sequent Scientific gains 4% on EIR from USFDA for Mangalore lab
https://www.moneycontrol.com/news/business/stocks/sequent-scientific-gains-4-on-eir-from-usfda-for-mangalore-lab-3286141.html

NewsBot @newsbot

SEQUENT

•

Nov 5 4:12 PM

Buy Sequent Scientific, target Rs 61: Rudra Shares & Stock Brokers
https://www.moneycontrol.com/news/business/markets/buy-sequent-scientific-target-rs-61-rudra-shares-stock-brokers-3129891.html

NewsBot @newsbot

SEQUENT

•

Nov 5 2:12 PM

Time to buy quality: Can start accumulating corporate banks, pharma stocks
https://www.moneycontrol.com/news/business/markets/for-monday-time-to-accumulate-quality-stocks-these-top-4-stocks-could-give-double-digit-return-in-short-to-medium-term-3127781.html

SEQUENT - Share Price - Fundamentals
Market Capitalization 1,773.62
Enterprise Value 1,810.74
Price to Earnings 4.65
Price to Book Value 1.93
Return on Capital Employed 0.43
Return on Equity 0.43
Face Value 2
Dividend Yield NA
SEQUENT Share Price - Technicals
SEQUENT - 52 Week High ₹89.25
SEQUENT - 52 Week Low ₹42.65
SEQUENT - Brokerage Reports
Date Brokerage Call Target
2-Aug-19 Nirmal Bang Buy 115
17-Apr-19 Joindre Capital Services Buy 116
View all SEQUENT - Share Targets - Broker Reports
SEQUENT Share Price - Historical (₹)
Date Open High Low Close
Sep 16 83.65 88.2 82.25 87.3
Sep 13 77.95 84.95 77.8 83.75
Sep 12 79.45 80.4 77.2 77.45
Sep 11 77 80.5 77 79.35
Sep 9 76.25 80.15 76.25 77.35
SEQUENT Share Price - Daily Moving Averages (DMA)
20 Day Moving Average ₹75.5
30 Day Moving Average ₹73.07
50 Day Moving Average ₹71.3
100 Day Moving Average ₹70.03
200 Day Moving Average ₹71.19
SEQUENT - Profit And Loss
CONSOLIDATED Mar-18 Mar-17 % Change
Revenue 106 378.4 -0.72
Operating Profit -20 13.42 -2.49
Profit Before Tax 409 -0.01 -40,901
Net Income 406 -0.01 -40,601
SEQUENT - Balance Sheet
CONSOLIDATED Mar-19 Mar-18 % Change
Shareholder's Funds 917 949 -0.03
Total Liabilities 101 32 2.16
Total Assets 1,019 981 0.04
SEQUENT - Cash Flow
CONSOLIDATED Mar-18 Mar-17 % Change
Cash from Operating Activity -4 -24.04 -0.83
Cash from Investing Activity 16 -46.84 -1.34
Cash from Financing Activity -12 70.97 -1.17
Net Cash Flow NA 0.08 -1
SEQUENT - Ratios
CONSOLIDATED Mar-18 Mar-17
Return on Assets 0.41 NA
Return on Equity 0.43 NA
Return on Capital Employed 0.43 0.01
SEQUENT - 3 year Growth
3 Year CAGR Growth in Revenue -0.72
3 Year CAGR Growth in Operating Profit -1.19
3 Year CAGR Growth in EBIDTA 2.71
3 Year CAGR Growth in Net Income 8.83
3 Yr CAGR Growth - Diluted EPS 0.23
SEQUENT - 5 year Growth
5 Year CAGR Growth in Revenue -0.55
5 Year CAGR Growth in Operating Profit -0.14
5 Year CAGR Growth in EBIDTA 28.22
5 Year CAGR Growth in Net Income 8.45
3 Yr CAGR Growth - Diluted EPS 1.71
SEQUENT Share Price - Recent News
NewsBot
Aug 21 3:28 PM
Sequent Scientific climbs 4% on EIR from USFDA for Bengaluru laboratory
Moneycontrol
NewsBot
Apr 16 10:18 PM
Buy Sequent Scientific; target of Rs 116: Joindre Capital Services
https://www.moneycontrol.com/news/business/stocks/buy-sequent-scientific-target-of-rs-116-joindre-capital-services-3834031.html
NewsBot
Dec 19 7:57 PM
Ten BSE 500 stocks rise 45-100% since October. Do you own any?
https://www.moneycontrol.com/news/business/markets/ten-bse-500-stocks-rise-45-100-since-october-do-you-own-any-3305601.html
NewsBot
Dec 19 7:37 PM
Ten BSE 500 stocks rose 45-100% in 2018. Do you own any?
https://www.moneycontrol.com/news/business/markets/ten-bse-500-stocks-rose-45-100-in-2018-do-you-own-any-3305601.html
NewsBot
Dec 13 7:02 PM
Sequent Scientific gains 4% on EIR from USFDA for Mangalore lab
https://www.moneycontrol.com/news/business/stocks/sequent-scientific-gains-4-on-eir-from-usfda-for-mangalore-lab-3286141.html
NewsBot
Nov 5 4:12 PM
Buy Sequent Scientific, target Rs 61: Rudra Shares & Stock Brokers
https://www.moneycontrol.com/news/business/markets/buy-sequent-scientific-target-rs-61-rudra-shares-stock-brokers-3129891.html
NewsBot
Nov 5 2:12 PM
Time to buy quality: Can start accumulating corporate banks, pharma stocks
https://www.moneycontrol.com/news/business/markets/for-monday-time-to-accumulate-quality-stocks-these-top-4-stocks-could-give-double-digit-return-in-short-to-medium-term-3127781.html
SEQUENT - Related Communities
WANBURY
Wanbury Ltd. Sector: Pharmaceuticals ...
PIRPHYTO
Piramal Phytocare Ltd. Sector: Pharma...
PARABDRUGS
Parabolic Drugs Ltd. Sector: Pharmace...
ORCHIDPHAR
Orchid Pharma Ltd. Sector: Pharmaceut...
BIOFILCHEM
Biofil Chemicals & Pharmaceuticals Lt...
WOCKPHARMA
Wockhardt Ltd. Sector: Pharmaceutical...
VIVIMEDLAB
Vivimed Labs Ltd. Sector: Pharmaceuti...
VENUSREM
Venus Remedies Ltd. Sector: Pharmaceu...
UNICHEMLAB
Unichem Laboratories Ltd. Sector: Pha...
TTKHLTCARE
TTK Healthcare Ltd. Sector: Pharmaceu...

Market Capitalization	1,773.62
Enterprise Value	1,810.74
Price to Earnings	4.65
Price to Book Value	1.93
Return on Capital Employed	0.43
Return on Equity	0.43
Face Value	2
Dividend Yield	NA

SEQUENT - 52 Week High	₹89.25
SEQUENT - 52 Week Low	₹42.65

Date	Brokerage	Call	Target
2-Aug-19	Nirmal Bang	Buy	115
17-Apr-19	Joindre Capital Services	Buy	116

Date	Open	High	Low	Close
Sep 16	83.65	88.2	82.25	87.3
Sep 13	77.95	84.95	77.8	83.75
Sep 12	79.45	80.4	77.2	77.45
Sep 11	77	80.5	77	79.35
Sep 9	76.25	80.15	76.25	77.35

20 Day Moving Average	₹75.5
30 Day Moving Average	₹73.07
50 Day Moving Average	₹71.3
100 Day Moving Average	₹70.03
200 Day Moving Average	₹71.19

CONSOLIDATED	Mar-18	Mar-17	% Change
Revenue	106	378.4	-0.72
Operating Profit	-20	13.42	-2.49
Profit Before Tax	409	-0.01	-40,901
Net Income	406	-0.01	-40,601

CONSOLIDATED	Mar-19	Mar-18	% Change
Shareholder's Funds	917	949	-0.03
Total Liabilities	101	32	2.16
Total Assets	1,019	981	0.04

CONSOLIDATED	Mar-18	Mar-17	% Change
Cash from Operating Activity	-4	-24.04	-0.83
Cash from Investing Activity	16	-46.84	-1.34
Cash from Financing Activity	-12	70.97	-1.17
Net Cash Flow	NA	0.08	-1

CONSOLIDATED	Mar-18	Mar-17
Return on Assets	0.41	NA
Return on Equity	0.43	NA
Return on Capital Employed	0.43	0.01

3 Year CAGR Growth in Revenue	-0.72
3 Year CAGR Growth in Operating Profit	-1.19
3 Year CAGR Growth in EBIDTA	2.71
3 Year CAGR Growth in Net Income	8.83
3 Yr CAGR Growth - Diluted EPS	0.23

5 Year CAGR Growth in Revenue	-0.55
5 Year CAGR Growth in Operating Profit	-0.14
5 Year CAGR Growth in EBIDTA	28.22
5 Year CAGR Growth in Net Income	8.45
3 Yr CAGR Growth - Diluted EPS	1.71

SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Help About Privacy Terms Disclaimers Refunds

SEQUENT Share Price Discussion

SEQUENT Discussion Forum

SEQUENT - Share Price - Fundamentals

SEQUENT Share Price - Technicals

SEQUENT - Brokerage Reports

SEQUENT Share Price - Historical (₹)

SEQUENT Share Price - Daily Moving Averages (DMA)

SEQUENT - Profit And Loss

SEQUENT - Balance Sheet

SEQUENT - Cash Flow

SEQUENT - Ratios

SEQUENT - 3 year Growth

SEQUENT - 5 year Growth

SEQUENT Share Price - Recent News

SEQUENT - Related Communities